Colleen M. Costelloe, M.D.
Department of Musculoskeletal Imaging, Division of Diagnostic Imaging
About Dr. Colleen M. Costelloe
Colleen Costelloe, MD joined the Musculoskeletal section of the Department of Diagnostic Radiology at The University of Texas MD Anderson Cancer Center in 2003 upon completing a fellowship in musculoskeletal radiology at Tulane University Health Sciences Center in New Orleans, LA. Dr. Costelloe is engaged in the clinical practice of radiology, the training and education of residents and fellows in musculoskeletal radiology and oncological research endeavors related to her field. Her primary clinical and research interests include magnetic resonance imaging (MRI) and PET/CT of primary bone tumors and bone metastases. Dr. Costelloe is the primary author or a contributing author on over 50 scientific publications. Her most influential contribution is original research demonstrating the utility of FDG PET/CT as in indicator of survival in patients with osteosarcoma. She has also published several cutting-edge pieces of original research demonstrating the utility of whole-body MRI in breast cancer patients with bone metastases. In addition to publications in leading medical journals, Dr. Costelloe has presented her work at major national and international meetings such as Radiologic Society of North America (RSNA).
Read More
Present Title & Affiliation
Primary Appointment
Professor, Department of Musculoskeletal Imaging, Division of Diagnostic Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas Medical School at Houston, Houston, TX
Dual/Joint/Adjunct Appointment
Professor, Department of Musculoskeletal Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas Medical School at Houston, Houston, TX
Research Interests
MRI and FDG PET/CT of primary and metastatic bone tumors and lymphoma
Clinical Interests
Dr. Costelloe's clinical interests are MRI, PET/CT radiography and CT.
Education & Training
Degree-Granting Education
| 1997 | The University of Texas Health Science Center, Houston, Texas, US, MD |
| 1993 | Louisiana State University, Baton Rouge, Louisiana, US, BS in Zoology |
Postgraduate Training
| 2002-2003 | Clinical Fellowship, Musculoskeletal Radiology, Tulane University Health Sciences Center, Edward DeMouy, M.D, New Orleans, Louisiana |
| 1998-2002 | Clinical Residency, Diagnostic Radiology, Tulane University Health Sciences Center, Harold Neitzschman, M.D, New Orleans, Louisiana |
| 1997-1998 | Clinical Internship, General Surgery, Spartanburg Regional Medical Center, Henry G. Kelley, M.D, Spartanburg, South Carolina |
Board Certifications
| 2002 | American Board of Radiology |
Experience & Service
Other Appointments/Responsibilities
Radiology Representative, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - Present
Institutional Committee Activities
Representative, Medical Records Committee, 2024 - 2025
Alternate Representative, Credentials Committee of the Medical Staff, 2023 - 2026
Member, Advanced Bone and Soft Tissue Imaging (ABASTI) Planning Committee, 2021 - Present
Honors & Awards
| 2025 | Fellow of the American College of Radiology, American College of Radiology |
| 2022 | Certificate of Merit, 108th Scientific Assembly and Annual Meeting of Radiological Society of North America |
| 2004 | Certificate of Merit, 90th Scientific Assembly and Annual Meeting of Radiological Society of North America |
| 2002 | Leon J. Menville Outstanding Research Award, Tulane University Health Science Center |
| 2001 | Resident Trainee Award, Radiological Society of North America |
| 1993 | Cum Laude, Louisiana State University |
| 1993 | Phi Beta Kappa, Louisiana State University |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Valenzuela RF, Duran Sierra EJ, Canjirathinkal MA, Amini B, Hwang KP, Ma J, Torres KE, Stafford RJ, Wang WL, Benjamin RS, Bishop AJ, Madewell JE, Murphy WA, Costelloe CM. Novel use and value of contrast-enhanced susceptibility-weighted imaging morphologic and radiomic features in predicting extremity soft tissue undifferentiated pleomorphic sarcoma treatment response. JCO Clin Cancer Inform 9:e2400042, 2025. e-Pub 2025. PMID: 39841956.
- Valenzuela RF, Duran-Sierra E, Canjirathinkal M, Amini B, Torres KE, Benjamin RS, Ma J, Wang WL, Hwang KP, Stafford RJ, Wu C, Zarzour AM, Bishop AJ, Lo S, Madewell JE, Kumar R, Murphy WA, Costelloe CM. Perfusion-weighted imaging with dynamic contrast enhancement (PWI/DCE) morphologic, qualitative, semiquantitative, and radiomics features predicting undifferentiated pleomorphic sarcoma (UPS) treatment response. Sci Rep 14(1):21681, 2024. e-Pub 2024. PMID: 39289469.
- Valenzuela RF, Duran-Sierra E, Canjirathinkal M, Amini B, Torres KE, Benjamin RS, Ma J, Wang WL, Hwang KP, Stafford RJ, Wu C, Zarzour AM, Bishop AJ, Lo S, Madewell JE, Kumar R, Murphy Jr WA, Costelloe CM. Radiomics by quantitative diffusion-weighted MRI for predicting response in patients with extremity soft-tissue undifferentiated pleomorphic sarcoma. J Radiol Oncol 8(2):064-071, 2024. e-Pub 2024.
- Valenzuela RF, Duran-Sierra E, Canjirathinkal MA, Amini B, Ma J, Hwang KP, Stafford RJ, Torres KE, Zarzour MA, Livingston JA, Madewell JE, Murphy WA, Costelloe CM. Contrast-enhanced susceptibility weighted imaging (CE-SWI) for the characterization of musculoskeletal oncologic pathology: a pictorial essay on the initial five-year experience at a cancer institution. J Radiol Oncl 8:030-045, 2024. e-Pub 2024.
- Sierra ED, Valenzuela R, Canjirathinkal MA, Costelloe CM, Moradi H, Madewell JE, Murphy WA, Amini B. Cancer radiomic and perfusion imaging automated framework: validation on musculoskeletal tumors. JCO Clin Cancer Inform 8:e2300118, 2024. e-Pub 2024. PMID: 38181324.
- Samet JD, Alizai H, Chalian M, Costelloe C, Deshmukh S, Kalia V, Kamel S, Mhuircheartaigh JN, Saade J, Walker E, Wessell D, Fayad LM. Society of skeletal radiology position paper - recommendations for contrast use in musculoskeletal MRI: when is non-contrast imaging enough?. Skeletal Radiol 53(1):99-115, 2024. e-Pub 2024. PMID: 37300709.
- Sierra ED, Valenzuela R, Canjirathinkal MA, Costelloe CM, Moradi H, Madewell JE, Murphy WA, Amini B. Cancer radiomic and perfusion imaging automated framework: validation on musculoskeletal tumors. JCO Clin Cancer Inform 8:e2300118, 2024. e-Pub 2024. PMID: 38181324.
- Valenzuela RF, Duran Sierra E, Canjirathinkal MA, Costelloe CM, Madewell JE, Murphy, Jr WA, Amini B. Early results in novel use of contrast-enhanced susceptibility-weighted imaging in the assessment of response and progression in desmoid fibromatosis: pilot study in a specialized cancer institution. Tumor Discov 2(3):1-9, 2023. e-Pub 2023.
- Amini B, Chenglei L, Duran-Sierra E, Wang WL, Canjirathinkal MA, Moradi H, Green WN, Madewell JE, Costelloe CM, Murphy WA, Valenzuela RF. Role of apparent diffusion coefficient map-based first-and high-order radiomic features for the discrimination of sacral chordomas and chondrosarcomas with overlapping conventional imaging features. JCO Precis Oncol 7(7):e2300243, 2023. e-Pub 2023. PMID: 38127828.
- Valenzuela RF, Amini B, Duran-Sierra E, Canjirathinkal MA, Madewell JE, Costelloe CM, Murphy WA. Multiparametric MRI for the assessment of treatment effect and tumor recurrence in soft-tissue sarcoma of the extremities. J Radiol Oncol 7(3):058-065. e-Pub 2023.
- Amini B, Chenglei L, Duran-Sierra E, Wang WL, Canjirathinkal MA, Moradi H, Green WN, Madewell JE, Costelloe CM, Murphy WA, Valenzuela RF. Role of apparent diffusion coefficient map-based first-and high-order radiomic features for the discrimination of sacral chordomas and chondrosarcomas with overlapping conventional imaging features. JCO Precis Oncol 7(7):e2300243, 2023. e-Pub 2023. PMID: 38127828.
- Amini B, Murphy, Jr WA, Haygood T, Kumar R, McEnery KW, Madewell JE, Mujtaba BM, Wei W, Costelloe CM. Gadolinium-based contrast agents improve detection of recurrent soft-tissue sarcoma at MRI. Radiol Imaging Cancer 2(2):e190046. e-Pub 2020. PMID: 33778705.
- Mujtaba B, Hanafy AK, Largo RD, Taher A, Madewell JE, Costelloe CM, Layman RR, Morani AC. The lumbar artery perforator flap: clinical review and guidance on image reporting. Clin Radiol 74(10):756-762, 2019. e-Pub 2019. PMID: 31300211.
- Salem U, Amini B, Chuang HH, Daw NC, Wei W, Haygood TM, Madewell JE, Costelloe CM. 18 F-FDG PET/CT as an Indicator of Survival in Ewing Sarcoma of Bone. J Cancer 8(15):2892-2898, 2017. e-Pub 2017. PMID: 28928879.
- Mitri Z, Nanda R, Blackwell K, Costelloe CM, Hood I, Wei C, Brewster AM, Ibrahim NK, Koenig KB, Hortobagyi GN, Van Poznak C, Rimawi MF, Moulder-Thompson S. TBCRC-010: Phase I/II Study of Dasatinib in Combination with Zoledronic Acid for the Treatment of Breast Cancer Bone Metastasis. Clin Cancer Res 22(23):5706-5712, 2016. e-Pub 2016. PMID: 27166393.
- Pinnix CC, Shah JJ, Chuang H, Costelloe CM, Medeiros LJ, Wogan CF, Reed VK, Smith GL, Milgrom SA, Patel K, Huo J, Turturro F, Romaguera J, Fayad LE, Oki Y, Fanale MA, Westin JR, Nastoupil L, Hagemeister FB, Rodriguez AM, Qazilbash MH, Shah ND, Bashir Q, Ahmed S, Nieto Y, Hosing C, Rohren E, Dabaja BS. Doxorubicin-Based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution Review. Clin Lymphoma Myeloma Leuk 16(3):122-128, 2016. e-Pub 2016. PMID: 26795083.
- Pinnix CC, Dabaja B, Ahmed MA, Chuang HH, Costelloe CM, Wogan CF, Reed V, Romaguera JE, Neelapu S, Oki Y, Rodriguez A, Fayad L, Hagemeister FB, Nastoupil L, Turturro F, Fowler N, Fanale M, Nieto Y, Khouri I, Ahmed S, Medeiros LJ, Davis RE, Westin J. Single-Institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by flurodeoxyglucose positron emission tomography. Int J Radiat Oncol Biol Phys 92(1):113-121, 2015. e-Pub 2015.
- Amini B, Madewell JE, Chuang HH, Haygood TM, Hobbs BP, Fox PS, Bassett RL, Costelloe CM. Differentiation of benign fluid collections from soft-tissue sarcomas on FDG-PET/CT. J Cancer 5(5):328-35, 2014. e-Pub 2014. PMID: 24723975.
- Costelloe CM, Madewell JE, Kundra V, Harrell RK, Bassett RL, Ma J. Conspicuity of bone metastases on fast Dixon-based multisequence whole-body MRI: Clinical utility per sequence. Magn Reson Imaging 31(5):669-75, 2013. e-Pub 2013. PMID: 23290478.
- Hayashi N, Costelloe CM, Hamaoka T, Wei C, Niikura N, Theriault RL, Hortobagyi GN, Madewell JE, Ueno NT. A prospective study of bone tumor response assessment in metastatic breast cancer. Clinical Breast Cancer 13(1):24-30, 2013. e-Pub 2013. PMID: 23098575.
- Costelloe CM, Madewell JE. Radiography in the initial diagnosis of primary bone tumors. Am J Roentgenol 200(1):3-7, 2013. e-Pub 2013. PMID: 23255735.
- Costelloe CM, Chuang HH, Chasen BA, Pan T, Fox PS, Bassett RL, Madewell JE. Bone Windows for Distinguishing Malignant from Benign Primary Bone Tumors on FDG PET/CT. J Cancer 4(7):524-30, 2013. e-Pub 2013. PMID: 23983816.
- Costelloe CM, Murphy WA, Gladish GW, Rozner MA. Radiography of pacemakers and implantable cardioverter defibrillators. Am J Roentgenol 199(6):1252-8, 2012. e-Pub 2012. PMID: 23169716.
- Haygood TM, Wong J, Lin JC, Li S, Matamoros A, Costelloe CM, Yeung H, Sandler CM, Nunez RF, Kumar R, Madewell JE. Skeletal Muscle Metastases: A Three-part Study of a Not-so-rare Entity. Skeletal Radiol 41(8):899-909, 2012. e-Pub 2012. PMID: 22101865.
- Houssami N, Costelloe CM. Imaging Bone Metastases in Breast Cancer: Evidence on Comparative Test Accuracy. Ann Oncol 23(4):834-843, 2012. e-Pub 2012. PMID: 21896542.
- Costelloe CM, Kundra V, Ma J, Chasen BA, Rohren EM, Bassett RL, Madewell JE. Fast Dixon Whole-body MRI for Detecting Distant Cancer Metastasis: A Preliminary Clinical Study. J Magn Reson Imaging 35(2):399-408, 2012. e-Pub 2012. PMID: 21990095.
- Shah KB, Guha-Thakurta N, Schellingerhout D, Madewell JE, Kumar AJ, Costelloe CM. Comparison of gadolinium-enhanced fat-saturated T1-weighted FLAIR and fast spin-echo MRI of the spine at 3 T for evaluation of extradural lesions. Am J Roentgenol 197(3):697-703, 2011. e-Pub 2011. PMID: 21862814.
- Haygood TM, Brennan PC, Ryan J, Yamal JM, Liles L, O'Sullivan P, Costelloe CM, Fitzgerald NE, Jr MW. Central venous line placement in the superior vena cava and the azygos vein: differentiation on posteroanterior chest radiographs. Am J Roentgenol 196(4):783-7, 2011. e-Pub 2011. PMID: 21427325.
- Costelloe CM, Murphy WA, Haygood TM, Kumar R, McEnery KW, Stafford RJ, Roy A, Bassett RL, Harrell RK, Madewell JE. Comparison of half dose and full dose gadolinium MR contrast on the enhancement of bone and soft tissue tumors. Skeletal Radiol 40(3):327-333, 2011. e-Pub 2011. PMID: 20862469.
- Niikura N, Costelloe CM, Madewell JE, Hayashi N, Yu TK, Liu J, Palla SL, Tokuda Y, Theriault RL, Hortobagyi GN, Ueno NT. FDG-PET/CT compared with conventional imaging in the detection of distant metastases of primary breast cancer. Oncologist 16(8):1111-9, 2011. e-Pub 2011. PMID: 21765193.
- Niikura N, Liu J, Costelloe CM, Palla SL, Madewell JE, Hayashi N, Yu TK, Tokuda Y, Theriault RL, Hortobagyi GN, Ueno NT. Initial staging impact of fluorodeoxyglucose positron emission tomography/computed tomography in locally advanced breast cancer. Oncologist 16(6):772-82, 2011. e-Pub 2011. PMID: 21632453.
- Costelloe CM, Chuang HH, Madewell JE, Ueno NT. Cancer Response Criteria and Bone Metastases: RECIST 1.1, MDA and PERCIST. J Cancer 1:80-92, 2010. e-Pub 2010. PMID: 20842228.
- Grasu RM, Costelloe CM, Boddu K. Revisiting Anatomic Landmarks: Lateral Popliteal Approach for Sciatic Nerve Block Based on Magnetic Resonance Imaging. Reg Anesth Pain Med 35(3):227-230, 2010. e-Pub 2010. PMID: 20921831.
- Costelloe CM, Raymond AK, Fitzgerald NE, Mawlawi OR, Nunez RF, Madewell JE, Harrell RK, Bassett RL, Marom EM. Tumor necrosis in osteosarcoma: inclusion of the point of greatest metabolic activity from F-18 FDG PET/CT in the histopathologic analysis. Skeletal Radiol 39(2):131-40, 2010. e-Pub 2010. PMID: 19760279.
- Hamaoka T, Costelloe CM, Madewell JE, Liu P, Berry DA, Islam R, Theriault RL, Hortobagyi GN, Ueno NT. Tumour response interpretation with new tumour response criteria vs the World Health Organization criteria in patients with bone-only metastatic breast cancer. Br J Cancer 102(4):651-7, 2010. e-Pub 2010. PMID: 20104228.
- Costelloe CM, Rohren EM, Madewell JE, Hamaoka T, Theriault RL, Yu TK, Lewis VO, Ma J, Stafford RJ, Tari AM, Hortobagyi GN, Ueno NT. Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis. Lancet Oncol 10(6):606-614, 2009. e-Pub 2009. PMID: 19482249.
- Ma J, Costelloe CM, Madewell JE, Hortobagyi GN, Green MC, Cao G, Sun F, Kundra V. Fast Dixon-based multi-sequence and multi-planar MRI for whole body detection of cancer metastases. J Magn Reson Imaging 29(5):2254-1162, 2009. e-Pub 2009. PMID: 19388121.
- Costelloe CM, Macapinlac HA, Madewell JE, Fitzgerald NE, Mawlawi OR, Rohren EM, Raymond AK, Lewis VO, Anderson PM, Bassett RL, Harrell RK, Marom EM. 18F-FDG PET/CT as an indicator of progression-free and overall survival in osteosarcoma. J Nucl Med 50(3):340-347, 2009. e-Pub 2009. PMID: 19258257.
- Costelloe CM, Murphy WA, Madewell JE. Imaging chronic sclerosing osteitis of the diaphysis of tubular bones. Am J Roentgenol 192(3):736-42, 2009. e-Pub 2009. PMID: 19234272.
- Chang DW, Satterfield WC, Son D, Neto N, Madewell JE, Raymond AK, Patrick CW, Miller MJ, Costelloe CM, Weber KL. Use of Vascularized Periosteum or Bone to Improve Healing of Segmental Allografts after Tumor Resection: An Ovine Rib Model. Plast Reconstr Surg 123(1):71-78, 2009. e-Pub 2009. PMID: 19116538.
- Costelloe CM, Dickson K, Cody DD, Hernandez M, DeMouy EH. Computed tomography reformation in evaluation of fracture healing with metallic fixation: correlation with clinical outcome. J Trauma 65(6):1421-4, 2008. e-Pub 2008. PMID: 19101998.
- Costelloe CM, Eftekhari F, Petropoulos D. Radiography of Successful Bone Marrow Transplantation for Osteopetrosis. Skeletal Radiol 36(Suppl 1):34-37, 2007. e-Pub 2007. PMID: 16799785.
- Costelloe CM, Kumar R, Yasko AW, Murphy WA, Stafford RJ, Lewis VO, Lin PP, Madewell JE. Imaging characteristics of locally recurrent tumors of bone. Am J Roentgenol 188(3):855-863, 2007. e-Pub 2007. PMID: 17312079.
- Lin PP, Jaffe N, Herzog CE, Costelloe CM, Deavers MT, Kelly JS, Patel SR, Madewell JE, Lewis VO, Cannon CP, Benjamin RS, Yasko AW. Chemotherapy response is an important predictor of local recurrence in Ewing sarcoma. Cancer 109(3):603-11, 2007. e-Pub 2007. PMID: 17177205.
- Hamaoka T, Costelloe CM, Madewell JE, Hortobagyi GN, Ueno NT. Evidenced-based tumor response assessment with imaging in bone metastases from breast cancer. J Clin Oncol 22(14_suppl):840, 2004. e-Pub 2004. PMID: 28014228.
Invited Articles
- Costelloe CM, Lin PP, Chuang HH, Amini B, Chainitikun S, Yu TK, Ueno NT, Murphy WA, Madewell JE. Bone metastases: mechanisms of the metastatic process, imaging and therapy. Semin Ultrasound CT MR 42(2):164-183, 2021. e-Pub 2021. PMID: 33814103.
- Valenzuela RF, Madewell JE, Kundra V, Costelloe CM. Advanced imaging in musculoskeletal oncology: moving away from RECIST and embracing advanced bone and soft tissue tumor imaging (ABASTI)-part II-novel functional imaging techniques. Semin Ultrasound CT MR 42(2):215-227, 2021. e-Pub 2021. PMID: 33814107.
- Costelloe CM, Madewell JE. An approach to undiagnosed bone tumors. Semin Ultrasound CT MR 42(2):114-122, 2021. e-Pub 2021. PMID: 33814099.
- Valenzuela RF, Kundra V, Madewell JE, Costelloe CM. Advanced imaging in musculoskeletal oncology: moving away from RECIST and embracing advanced bone and soft tissue tumor imaging (ABASTI) - part I - tumor response criteria and established functional imaging techniques. Semin Ultrasound CT MR 42(2):201-214, 2021. e-Pub 2021. PMID: 33814106.
- Costelloe CM, Amini B, Madewell JE. Risks and benefits of gadolinium-based contrast enhanced MRI. Semin Ultrasound CT MR 41(2):260-274, 2020. e-Pub 2020. PMID: 32446435.
- Mujtaba B, Gu L, Largo RD, Amini B, Layman RR, Madewell JE, Costelloe CM. Video: Preoperative CT Angiography for Scapula Osteocutaneous Free Flap Reconstructions. AJR Am J Roentgenol 213(3):W143-W144, 2019. e-Pub 2019. PMID: 31166756.
- Mujtaba B, Synghal GK, Garvey P, Amini B, Haygood TM, Madewell JE, Costelloe CM. Video: Preoperative CT Angiography for Fibular Free Flap Reconstructions. Am J Roentgenol 210(6):W264, 2018. e-Pub 2018. PMID: 29702024.
- Costelloe CM, Chuang HH, Daw NC. PET/CT of Osteosarcoma and Ewing Sarcoma. Semin Roentgenol 52(4):255-268, 2017. e-Pub 2017. PMID: 28965545.
- McConnell M, Garvey P, Amini B, Haygood T, Madewell J, Costelloe CM. Video: Preoperative CT Angiography for Anterolateral Thigh Flap Reconstructions. Am J Roentgenol 208(3):W127, 2017. e-Pub 2017. PMID: 28026973.
- Costelloe CM, Chuang HH, Madewell JE. FDG PET for the Detection of Bone Metastases: Sensitivity, Specificity and Comparison with Other Imaging Modalities. (Cover Illustration). PET Clin 5(3):281-295, 2010. e-Pub 2010. PMID: 27157834.
- Costelloe CM, Murphy WA, Chasen BA. Musculoskeletal pitfalls in 18F-FDG PET/CT: self-assessment module. Am J Roentgenol 193(3 Suppl):S26-30, 2009. e-Pub 2009. PMID: 19696241.
- Costelloe CM, Yasko AW, Murphy WA, Kumar R, Lewis VO, Lin PP, Stafford RJ, Madewell JE. MRI of Locally Recurrent Soft Tissue Tumors of the Musculoskeletal System. The Internet Journal of Radiology 5(2):1-7, 2006. e-Pub 2006.
Manuals, Teaching Aids, Other Teaching Publications
- Costelloe CM. Musculoskeletal MRI protocol development - 1.5T, 2007.
- Costelloe CM. Musculoskeletal MRI Protocol Development - 3.0T, 2007.
Other Articles
- Costelloe CM, Lee HG Land shells on Quintana Beach: terrestrial shells of Texas from the Brazos River drainage 52(4):4-16, 2024.
- Costelloe CM, Chuang HH, Madewell JE FDG PET/CT of Primary Bone Tumors. Am J Roentgenol 202(6):W521-31, 2014. PMID: 24848845.
- Costelloe CM, Murphy WA, Chasen BA Musculoskeletal pitfalls in 18F-FDG PET/CT: pictorial review. Am J Roentgenol 193(3 Suppl):WS1-WS13, Quiz S26-30, 2009. PMID: 19696250.
- Costelloe CM, Fuller GN, Kumar AJ, Cline K, Neitzschman HR Radiology case of the month. Palmer mass and finger weakness. Fibrolipomatous hamartoma of median nerve distribution: 26 year follow up. J La State Med Soc 158(1):7-8, 2006. PMID: 16602477.
- Costelloe CM, Wilson S, DeMouy EH, Neitzschman HR Radiology case of the month. Rapidly expanding tumor of bone. Cystic giant cell tumor of bone. J La State Med Soc 155(4):185-186, 2003. PMID: 14506822.
- Costelloe CM, Dickson K, De Mouy E, Neitzschman HR Radiology case of the month. Chronic pain post fracture. Hypertrophic nonunion. J La State Med Soc 154(1):13-4, 2002. PMID: 17312603.
- Costelloe CM, Akers DL, Lang EK Thoracic outlet syndrome: case report and review. J La State Med Soc 153(10):504-10, 2001. PMID: 18350710.
- Costelloe CM, De Mouy EH, Neitzschman H Radiology case of the month. Primary tumor of bone. Conventional osteosarcoma. J La State Med Soc 153(7):347-349, 2001. PMID: 11519216.
- Costelloe CM, Neitzschman H Radiology case of the month. Asymptomatic abdominal mass in a child. Wilms' tumor (Nephroblastoma). J La State Med Soc 153(5):229-231, 2001. PMID: 11433928.
- Neitzschman HR, Costelloe CM, Willis RB, De Mouy EH Radiology case of the month. Congenital bone disorder associated with deformity, fracture, and pseudoarthrosis. Congenital tibial dysplasia--neurofibromatosis type I (NF1). J La State Med Soc 153(3):119-121, 2001. PMID: 11355506.
- Costelloe CM, De Mouy EH, Neitzschman HR Radiology case of the month. Congenital limb and bleeding disorder. Thrombocytopenia absent radius syndrome (TAR). J La State Med Soc 152(11):551-552, 2000. PMID: 11125506.
Abstracts
- Costelloe CM, Valenzuela RF, Amini B. Extension study following successful Pilot evaluating Contrast-Enhanced Susceptibility-Weighted Imaging First-Order and High-Order Radiomics for the assessment of Desmoid Fibromatosis Response (0901_1339_000092). e-Pub 2025.
- Valenzuela RF, Amini B, Costelloe CM. Soft-Tissue Leiomyosarcoma: Building a Reliable Multiparametric MRI-Based Model for Neo-Adjuvant Therapy Response Soft-Tissue Leiomyosarcoma: Building a Reliable Multiparametric MRI-Based Model for Neo-Adjuvant Therapy Response Assessment (0901_1339_000094). e-Pub 2025.
- Valenzuela RF, Amini B, Costelloe CM. Undifferentiated Pleomorphic Sarcoma: Building an Effective Multiparametric MRI (mpMRI) derived Predictive Treatment Response Model to Replace RECIST (0901_1339_000091). e-Pub 2025.
- Valenzuela RF, Duran-Sierra E, Canjirathinkal M, Costelloe C, Madewell J, Murphy W, Amini B. Novel use of contrast-enhanced susceptibility-weighted imaging (CE-SWI) in the treatment assessment of desmoid fibromatosis: Early results from a specialized cancer institution. 47th Society of Skeletal Radiology 2024 Annual Meeting, 2024. e-Pub 2024.
- Valenzuela RF, Duran-Sierra E, Canjirathinkal M, Costelloe C, Madewell J, Murphy W, Amini B. Novel use of contrast-enhanced susceptibility imaging (CE-SWI) in assessing treatment response in extremity soft-tissue undifferentiated pleomorphic sarcoma (UPS). 47th Society of Skeletal Radiology 2024 Annual Meeting, 2024. e-Pub 2024.
- Valenzuela RF, Duran-Sierra D, Canjirathinkal M, Costelloe C, Idrees H, Madewell J, Murphy W, Amini B. Multi-parametric MRI for the treatment assessment of lower extremity soft-tissue undifferentiated pleomorphic sarcoma (UPS). 47th Society of Skeletal Radiology 2024 Annual Meeting, 2024. e-Pub 2024.
- Valenzuela RF, Duran-Sierra E, Canjirathinkal M, Costelloe C, Idrees H, Madewell J, Murphy W, Amini B. Perfusion weighted-imaging with dynamic contrast enhancement (PWI/DCE) for the treatment assessment of extremity soft-tissue non-myxoid undifferentiated pleomorphic sarcoma (UPS). 47th Society of Skeletal Radiology 2024 Annual Meeting, 2024. e-Pub 2024.
- Valenzuela RF, Duran Sierra E, Canjirathinkal M, Costelloe CM, Madewell JE, Murphy WA, Amini B. Role of contrast-enhanced susceptibility-weighted imaging (CE-SWI) for the assessment of response and progression in desmoid fibromatosis. 2024 American Roentgen Ray Society Annual Meeting, 2024. e-Pub 2024.
- Valenzuela RF, Duran-Sierra E, Canjirathinkal M, Costelloe C, Madewell J, Murphy W, Amini B. Novel use of contrast-enhanced susceptibility imaging (CE-SWI) in assessing treatment response in extremity soft-tissue undifferentiated pleomorphic sarcoma (UPS). ESR European Congress of Radiology 2024 Science and Educational Programme, Vienna, Austria, 2024. e-Pub 2024.
- Valenzuela RF, Duran-Sierra E, Canjirathinkal M, Costelloe C, Idrees H, Madewell J, Murphy W, Amini B. Perfusion weighted imaging with dynamic contrast enhancement (PWI/DCE) for the treatment assessment of extremity soft-tissue non-myxoid undifferentiated pleomorphic sarcoma. ESR European Congress of Radiology 2024 Science and Educational Programme, Vienna, Austria, 2024. e-Pub 2024.
- Valenzuela RF, Duran-Sierra D, Canjirathinkal M, Costelloe C, Idrees H, Madewell J, Murphy W, Amini B. Multiparametric MRI for the treatment assessment of lower extremity soft-tissue undifferentiated pleomorphic sarcoma (UPS). ESR European Congress of Radiology 2024 Science and Educational Programme, Vienna, Austria, 2024. e-Pub 2024.
- Valenzuela RF, Duran-Sierra E, Canjirathinkal M, Costelloe C, Madewell J, Murphy W, Amini B. Novel use of contrast-enhanced susceptibility-weighted imaging (CE-SWI) in the treatment assessment of desmoid fibromatosis: early results from a specialized cancer institution. ESR European Congress of Radiology 2024 Science and Educational Programme, Vienna, Austria, 2024. e-Pub 2024.
- Amini B, Duran-Sierra E, Madewell J, Murphy W, Costelloe C, Valenzuela RF. Advanced MRI can be used to determine percent necrosis in leiomyosarcoma. ESR European Congress of Radiology 2024 Science and Educational Programme, Vienna, Austria, 2024. e-Pub 2024.
- Valenzuela RF, Duran Sierra E, Amini B, Antony M, Madewell JE, Costelloe CM, Murphy WA. Apparent diffusion coefficient (ADC) high-order radiomic of baseline and post-treatment advanced MRI of extremity soft-tissue non-myxoid undifferentiated pleomorphic sarcoma. Connective Tissue Oncology Society 2023 Annual Meeting, Dublin Ireland, 2023. e-Pub 2023.
- Valenzuela RF, Amini B, Duran Sierra E, Antony M, Costelloe CM, Madewell JE, Murphy WA. Early results in novel use of contrast-enhanced susceptibility-weighted imaging in the assessment of response and progression in desmoid fibromatosis: pilot study in a specialized cancer institution. Connective Tissue Oncology Society 2023 Annual Meeting, Dublin Ireland, 2023. e-Pub 2023.
- Valenzuela RF, Duran Sierra E, Amini B, Antony M, Madewell JE, Costelloe CM, Murphy WA. Contrast-enhanced susceptibility imaging (CE-SWI) morphologic, first & high-order radiomic features value in assessing treatment response in extremity soft-tissue undifferentiated pleomorphic sarcoma. Connective Tissue Oncology Society 2023 Annual Meeting, Dublin Ireland, 2023. e-Pub 2023.
- Valenzuela R, Amini B, Antony M, Duran Sierra E, Costelloe CM, Madewell JE, Murphy WA. Baseline and post-treatment advanced MRI of extremities soft-tissue non-myxoid undifferentiated pleomorphic sarcoma. Connective Tissue Oncology Society 2023 Annual Meeting, Dublin Ireland, 2023. e-Pub 2023.
- Duran Sierra E, Valenzuela RF, Antony M, Costelloe CM, Moradi H, Madewell JE, Murphy WA, Amini B. Cancer radiomic and perfusion imaging (CARPI) automated framework: validation on musculoskeletal tumors in a specialized cancer center. Connective Tissue Oncology Society 2023 Annual Meeting, Dublin Ireland, 2023. e-Pub 2023.
- Valenzuela RF, Duran Sierra E, Amini B, Antony M, Madewell JE, Costelloe CM, Murphy WA. Role of perfusion weighted imaging with dynamic contrast enhanced (PWI/DCE) for the treatment assessment of extremity soft-tissue non-myxoid undifferentiated. Connective Tissue Oncology Society 2023 Annual Meeting, Dublin Ireland, 2023. e-Pub 2023.
- Chenglei L, Valenzuela RF, Green W, Canjirathinkal M, Griggs M, Wang W L, Murphy Jr WA, Amini B, Madewell JE, Costelloe C. Apparent diffusion coefficient (ADC) first-order radiomic features differentiate pelvic chordomas and chondrosarcomas. ESR European Congress of Radiology 2023 Science and Educational Programme, 2023. e-Pub 2023.
- Valenzuela, RF, Amini B, Canjirathinkal M, Duran-Sierra E, Murphy Jr WA, Idrees H, Madewell JE, Costelloe C. Baseline and post-treatment advanced MRI of extremity soft-tissue non-myxoid undifferentiated pleomorphic sarcoma. ESR European Congress of Radiology 2023 Science and Educational Programme, 2023. e-Pub 2023.
- Duran-Sierra E, Valenzuela RF, Canjirathinkal M, Costelloe C, Moradi H, Madewell JE, Murphy Jr WA. Diffusion-Weighted imaging first order radiomic features differentiate pelvic chordomas and chondrosarcomas. 46th Society of Skeletal Radiology 2023 Annual Meeting, 2023. e-Pub 2023.
- Valenzuela RF, Amini B, Canjirathinkal M, Idrees H, Madewell JE, Costelloe C, Murphy, W. Susceptibility-Weighted imaging (SWI) in benign and malignant tumors of musculoskeletal system. ESR European Congress of Radiology 2023 Science and Educational Programme, Vienna, Austria. e-Pub 2023.
- Duran-Sierra E, Valenzuela RF, Canjirathinkal M, Madewell J, Murphy W, Costelloe C, Amini B. Susceptibility imaging (SWI) morphologic patterns and high-order radiomics of baseline and post-treatment advanced MRI of extremity soft-tissue undifferentiated pleomorphic sarcoma. ESR European Congress of Radiology 2023 Science and Educational Programme, Vienna, Austria. e-Pub 2023.
- Duran-Sierra E, Valenzuela RF, Canjirathinkal M, Murphy, W, Madewell JE, Costelloe C, Amini B. Apparent diffusion coefficient (ADC) high-order radiomics of baseline and post-treatment advanced MRI of extremity soft-tissue undifferentiated pleomorphic sarcoma. ESR European Congress of Radiology 2023 Science and Educational Programme, Vienna, Austria. e-Pub 2023.
- Duran-Sierra E, Valenzuela RF, Canjirathinkal M, Costelloe C, Moradi H, Madewell JE, Murphy Jr WA, Amini B. Optimized automated workflow for radiomic feature extraction from static and dynamic magnetic resonance imaging (MRI) of soft tissue sarcoma. ESR European Congress of Radiology 2023 Science and Educational Programme, 2023. e-Pub 2023.
- Duran-Sierra E, Valenzuela RF, Canjirathinkal M, Costelloe C, Moradi H, Madewell JE, Murphy, Jr WA, Amini B. Optimized automated workflow for radiomic feature extraction from static and dynamic magnetic resonance imaging (MRI) of soft tissue sarcoma. 46th Society of Skeletal Radiology 2023 Annual Meeting, 2023. e-Pub 2023.
- Costelloe CM, Madewell JE, Eshed I, Marom E. Indications for Gadolinium-Based MRI Contrast in MSK Oncology. 119th Annual Meeting of The American Roetgen Ray Society, Honolulu, HI. e-Pub 2019.
- Gu L, Costelloe CM, Mujtaba B. Preoperative CT Angiography for Scapula Osteocutaneous Free Flap Reconstructions. 119th Annual Meeting of The American Roetgen Ray Society, Honolulu, HI. e-Pub 2019.
- Amini B, Haygood TM, Kumar R, Madewell JE, McEnery KW, Mujtaba B, Murphy WA, Wei W, Costelloe CM. Gadolinium-based intravenous contrast administration for dectection of recurrent soft tissue sarcomas. American Roentgen Ray Society Annual Meeting, Washington, DC. e-Pub 2018.
- Synghal G, Costelloe CM, Amini B, Haygood TM, Madewell JE, Mujtaba B. Preoperative Computed Tomography Angiography (CTA) for Fibular Flap Reconstructions. AUR 2018 Research Paper Abstracts, 66th Annual Meeting of The Association of University Radiologists, Orlando, FL:102. e-Pub 2018.
- Amini B, Haygood TM, Kumar R, Madewell JE, McEnery KW, Mujtaba B, Murphy WA, Wei W, Costelloe CM. Utility of Intravenous Contrast Administration for Detection of Recurrent Soft Tissue Sarcomas on MRI. Society of Skeletal Radiology Annual Meeting, Austin, TX 47:437-454, 2018. e-Pub 2018. PMID: 29236141.
- Son JB, Costelloe C, Hwang KP, Zhang T, Bayram E, Hazle J, Ma J. Flexible spin echo triple echo Dixon (flexible STED) for fat suppressed T1-weighted imaging. 25th Annual Meeting of the International Society for Magnetic Resonance in Medicine, Honolulu, HI - Abstract Book, 2017. e-Pub 2017.
- Sathyanarayanan V, Chihara D, Fanale MA, Costelloe CM, Ghonimi E, Shen C, Vega F, Dabaja BS, Oki Y, Zhou S, Hubert C. Prognostic Value of PET-CT in early stage Hodgkin Lymphoma (HL) using updated 5 point scoring system. American Society of Clinical Oncology, Annual Meeting, Chicago, IL - e19013, 2016. e-Pub 2016.
- Mitri Z, Nanda R, Blackwell K, Costelloe CM, Hood I, Brewster A, Ibrahim N, Koenig K, Hortobagyi G, Van Poznak C, rimawi M, Moulder S. Phase I/II Study of Dasatinib in Combination with Zoledronic Acid (ZA) for the Treatment of Breast Cancer Bone Metastasis (MBC-bone). American Society of Clinical Oncology, Annual Meeting, Chicago, IL - Abstract Book, 2015. e-Pub 2015.
- Salem U, Amini B, Chuang HH, Daw N, Wei W, Haygood TM, Madewell JE, Costelloe CM. 18F-FDG PET/CT as an indicator of survival in bone primary Ewing sarcoma. Society of Skeletal Radiology, Annual Meeting, Scottsdale, AZ - Abstract Book, 2015. e-Pub 2015.
- Salem U, Amini B, Chuang HH, Daw N, Wei W, Haygood TM, Madewell JE, Costelloe CM. 18F-FDG PET/CT as an indicator of survival in bone primary Ewing sarcoma. Radiological Society of North America Annual Meeting, Chicago, IL - Abstract Book, 2014. e-Pub 2014.
- Costelloe CM, Jessop A, Chuang HH, Madewell JM. FDG PET/CT of primary bone tumors. American Roetgen Ray Society, Vancouver Canada- Abstract Book, 2012. e-Pub 2012.
- Costelloe CM, Ma J, Madewell JE, Chasen BA, Rohren EM, Bassett RL, Kundra V. Fast Dixon-based whole body MRI: sensitivity and specificity in comparison with bone scan. Society of Skeletal Radiology, Scottsdale, AZ- Abstract Book, 2011. e-Pub 2011.
- Costelloe CM, Ma J, Madewell JE, Harrell RK, Bassett RL, Kundra V. Conspicuity of bone lesions on fast Dixon-based whole body MRI with diffusion-weighted sequences: estimate of clinical utility per sequence. World Molecular Imaging Conference, Kyoto, Japan- Abstract book, 2010. e-Pub 2010.
- Costelloe CM, Murphy WA, Madewell JE, Haygood TM, Kumar R, McEnery KW, Stafford RJ, Roy A, Harrell R, Bassett R. The effect of half dose intravenous gadolinium MR contrast on the conspicuity of bone and soft tissue lesions. Radiological Society of North America Annual Meeting - Abstract Book, 2009. e-Pub 2009.
- Shah KB, Costelloe CM, Guha-Thakurta N, Madewell JE, Liu P, Kumar AJ. Diagnostic quality of contrast-enhanced T1 FLAIR vs Contrast-enhanced T1 spin echo sagittal imaging in the spine at 3T. Radiological Society of North America, Chicago, IL- Abstract book, 2009. e-Pub 2009.
- Runge KR, Reed BJ, Costelloe CM, Madewell JE, Kundra V, Ma J. Whole Body MRI for evaluation of breast cancer metastases. Society of Magnetic Resonance in Medicine, Honolulu, HI- Abstract book, 2009. e-Pub 2009.
- Haygood T, O'Sullivan P, Yamal JM, Liles L, Madewell JE, Chasen B, Fitzgerald N, Costelloe CM, Ng C, Sandler CM, Lano E, McEnery K, Jr MW. Determination of central line position in the superior vena cava or azygous vein on frontal chest radiographs. American Roentgen Ray Society, Boston, MA- Abstract book, 2009. e-Pub 2009.
- Costelloe CM, Madewell JE, Raymond AK, Lewis VO, Fitzgerald NE, Macapinlac H. FDG PET/CT as an indicator of progression-free survival in osteosarcoma. Radiological Society of North America Annual Meeting - Abstract Book, 2008. e-Pub 2008.
- Costelloe CM, Raymond AK, Madewell JE, Fitzgerald NE, Macapinlac H, Lewis VO. Physical location of SUVmax on FDG PET/CT in primary osteosarcoma: correlation with histologic sampling of the surgical specimen. Radiological Society of North American Annual Meeting - Abstract Book, 2008. e-Pub 2008.
- Costelloe CM, Madewell J, Macapinlac H, Haygood T, Chasen B, Fitzgerald N, Eftekhari F, Sabloff B, Marom E. Musculoskeletal PET-CT imaging pitfalls. American Roentgen Ray Society Annual Meeting - Abstract Book, 2008. e-Pub 2008.
- Ma J, Costelloe CM, Kundra V, Zhou Y, Green M, Hortobagyi GN, Madewell JE. Single session whole body T-2 weighted and T-1 weighted MRI (both with and without fat suppression). Society of Magnetic Resonance in Medicine, Berlin, Germany, 2007. e-Pub 2007.
- Lin J, Haygood T, Madewell JE, Sandler CM, Matamoros A, Bruzzi J, Costelloe CM. Exhibit-Skeletal muscle metastases: imaging and epidemiology. American Roetgen Ray Society, Orlando, FL- Abstract Book, 2007. e-Pub 2007.
- Costelloe CM, Eftekhari F, Madewell JE, Murphy WA. Exhibit-Long term follow-up of chronic sclerosing osteitis of tubular bones. Radiological Society of North America, Chicago, IL- Abstract book, 2006. e-Pub 2006.
- Cannon BA, Kumar AJ, Costelloe CM, LeRoux, Ma J. Quantitative diffusion and fat imaging of vertebral compression fractures. ISMRM Annual Meeting. Seattle, Washington, 2006. e-Pub 2006.
- Costelloe CM, Gladish G, Jr MW, Rozner MA. Radiography of implantable cardiac pacemakers and defibrillators. American Roentgen Ray Society Annual Meeting - Abstract Book, 2006. e-Pub 2006.
- Hamaoka, T, Madewell JE, Costelloe CM, Islam R, Rondon G, Ayers GD, Champlin RE, Berry DA, Hortobagyi GN, Ueno NT. Accurate response assessment of breast cancer bone metastasis by computed tomography using new response criteria. American Society of Clinical Oncology. Orlando, Florida, 2005. e-Pub 2005.
- Costelloe CM, Sepulveda K, McAlee K, Kumar R, Madewell J, Murphy W. Magnetic resonance imaging of locally recurrent soft tissue tumors - Program guide. Radiological Society of North America, 90th Scientific Assembly and Annual Meeting, Chicago, Illinois - Abstract Book, 2004. e-Pub 2004.
- Costelloe CM, Sepulveda K, Devine C, McAlee K, Kumar R, Madewell J. Imaging characteristics of locally recurrent primary tumors of bone. Radiological Society of North America, 90th Scientific Assembly and Annual Meeting, Chicago, Illinois - Abstract Book, 2004. e-Pub 2004.
- DeMouy, EH, Dickson KF, Costelloe CM, Myers L. CT reformattation in evaluation of fracture healing with metal fixation: Correlation with clinical outcome. Radiological Society of North America, 87th Scientific Assembly and Annual Meeting, Chicago, Illinois-Abstract Book, 2001. e-Pub 2001.
Book Chapters
- Costelloe CM, Lin PP, Chuang HH, Amini B, Ueno NT, Chainitikun S, Yu TK, Madewell JE. Bone metastases. In: Oncologic Imaging: A Multidisciplinary Approach. 2nd. Elsevier, 587-605, Chapter 34, 2022.
- Costelloe CM, Valenzuela RF, Chuang HH, Madewell JE. Imaging of Bone Metastases. In: Cancer Metastasis Through the Lymphovascular System: A Comprehensive Textbook. Springer, 295-308, 2022.
- Costelloe, CM, Madewell, JE. Clinical Considerations and Imaging of Bone Tumors. In: Dorfman and Czerniak's Bone Tumors. 2nd. Elsevier, 57-95, 2015.
- Madewell JE, Costelloe CM, Haygood TM, Kumar RJ, Murphy WM. Bone Sarcoma Imaging. In: Bone Sarcoma. MD Anderson Cancer Care Series. Springer, Boston, MA, 7-29, 2013.
- Costelloe CM, Ueno NT, Lin PP, Yu TK, Madewell JE. Bone metastases. In: Oncologic Imaging: A Multidisciplinary Approach. Elsevier, 2012.
- Costelloe CM, Lin PP. Follow-up evaluation and surveillance. In: Bone Sarcoma Volume VII of the UT M.D. Anderson Cancer Center Care Series. Alan Yasko and Patrick Lin, 2007.
- Madewell JE, Costelloe CM, Haygood TM, Kumar R, Jr MW. Bone Sarcoma Imaging. In: Bone Sarcoma. M.D. Anderson Cancer Center Care Series. Springer, Boston, MA, 2007.
Letters to the Editor
- Costelloe CM. Letter from the guest editor. Semin Ultrasound CT MR 42: 113, 2021.
- Costelloe CM, Madewell JE. Reply: To PMID 23255735. AJR Am J Roentgenol 201: W771, 2013.
- Costelloe CM, Madewell JE. Reply: Radiography in the Initial Diagnosis of Primary Bone Tumors. AJR Am J Roentgenol 200: 3-7, 2013.
- Hamaoka T, Costelloe CM, Madewell JE, Liu P, Hortobagyi GN, Ueno NT. Reply: Assessment of therapeutic response in patients with metastatic skeletal disease: suggested modifications for the MDA response classification criteria. Br J Cancer, 2010.
Selected Presentations & Talks
Local Presentations
- 2017. Post-Therapeutic Sciatic Nerve Changes on MRI. Conference. DI Trainee Research Symposium 2017. Houston, TX, US.
- 2016. Reduce Operative Miscounts and RFO Protocols (Presenter). Conference. 2016 Diagnostic Imaging Celebrating Improvement. Houston, TX, US.
- 2016. Reduce Operative Miscounts and RFO Protocols (Presenter). Conference. Diagnostic Imaging Celebrate Solutions. Houston, TX, US.
- 2015. 18F-FDG PET/CT as an Indicator of Survival in Bone Primary Ewing Sarcoma. Conference. Trainee Research Day. Houston, TX, US.
- 2014. The Added Value of a 3-D, Heavily T2-Weighted Sequence for MRI Imaging of the Brachial Plexus. Conference. Houston, TX, US.
- 2004. MRI of the Knee (Presenter). Conference. Tenth Annual Houston Radiological Society Imaging Perspective. Advances of Interventional and Musculoskeletal Radiology. Houston, TX, US.
- 1994. DNA fingerprinting of mycobacterium tuberculosis from HIV positive patients in Houston (Presenter). Conference. Summer Research Program. Houston, TX, US.
Regional Presentations
- 2012. Differentiation of Benign Fluid Collections from Sarcomas on FDG-PET/CT. Conference. Differentiation of Benign Fluid Collections from Sarcomas on FDG-PET/CT. San Antonio, TX, US.
- 2007. Behavior and Management of Osseous Metastases. Conference. Behavior and Management of Osseous Metastases. Boston, MA, US.
- 2007. Integrated Imaging of the Bony Skeleton: Behavior and Management of Osseous Metastases. Conference. Integrated Imaging of the Bony Skeleton: Behavior and Management of Osseous Metastases. Boston, MA, US.
- 2007. Musculoskeletal Pitfalls in PET/CT. Conference. Musculoskeletal Pitfalls in PET/CT. Boston, MA, US.
- 2004. Musculoskeletal Tumor Mimics. Conference. Musculoskeletal Tumor Mimics. San Antonio, TX, US.
- 2004. Imaging of local recurrence of musculoskeletal malignancies. Conference. Imaging of local recurrence of musculoskeletal malignancies. San Antonio, TX, US.
- 2002. Exhibit-Laparoscopic nonanatomical partial left hepatic lobe resection: A new safe alternative. Conference. Exhibit-Laparoscopic nonanatomical partial left hepatic lobe resection: A new safe alternative. New Orleans, LA, US.
- 2002. Reformatted CT in the evaluation of healing fractures fixed with hardware. Conference. Reformatted CT in the evaluation of healing fractures fixed with hardware. Point Clear, AL, US.
- 2001. CT reformattation in evaluation of fracture healing with metal fixation: Correlation with clinical outcome. Conference. CT reformattation in evaluation of fracture healing with metal fixation: Correlation with clinical outcome. New Orleans, LA, US.
National Presentations
- 2025. Oral Presentation, Undifferentiated Pleomorphic Sarcoma: Building an Effective Multiparametric MRI (mpMRI) derived Predictive Treatment Response Model to Replace RECIST (0901_1339_000091). Conference. 48th Society of Skeletal Radiology 2025 Annual Meeting. Santa Fe, New Mexico, US.
- 2025. Oral Presentation, Extension study following successful Pilot evaluating Contrast-Enhanced Susceptibility-Weighted Imaging First-Order and High-Order Radiomics for the assessment of Desmoid Fibromatosis Response (0901_1339_000092). Conference. 48th Society of Skeletal Radiology 2025 Annual Meeting. Santa Fe, New Mexico, US.
- 2025. Oral Presentation, Soft-Tissue Leiomyosarcoma: Building a Reliable Multiparametric MRI-Based Model for Neo-Adjuvant Therapy Response Assessment (0901_1339_000094). Conference. 48th Society of Skeletal Radiology 2025 Annual Meeting. Santa Fe, New Mexico, US.
- 2024. Exhibit, Role of contrast-enhanced susceptibility-weighted imaging (CE-SWI) for the assessment of response and progression in desmoid fibromatosis. Poster. 2024 American Roentgen Ray Society Annual Meeting. Boston, Massachusetts, US.
- 2024. Oral Presentation, Novel use of Contrast-Enhanced Susceptibility Imaging (CE-SWI) in assessing treatment response in extremity soft-tissue undifferentiated pleomorphic sarcoma (UPS). Conference. Oral Presentation, Novel use of Contrast-Enhanced Susceptibility Imaging (CE-SWI) in assessing treatment response in extremity soft-tissue undifferentiated pleomorphic sarcoma (UPS). San Juan, PR, US.
- 2024. Exhibit, Perfusion weighted-imaging with dynamic contrast enhancement (PWI/DCE) for the treatment assessment of extremity soft-tissue non-myxoid undifferentiated pleomorphic sarcoma (UPS). Conference. Exhibit, Perfusion weighted-imaging with dynamic contrast enhancement (PWI/DCE) for the treatment assessment of extremity soft-tissue non-myxoid undifferentiated pleomorphic sarcoma (UPS). San Juan, PR, US.
- 2024. Exhibit, Novel Use of Contrast-Enhanced Susceptibility-Weighted Imaging (CE-SWI) in the Treatment Assessment of Desmoid Fibromatosis: Early results from a Specialized Cancer Institution. Conference. Exhibit, Novel Use of Contrast-Enhanced Susceptibility-Weighted Imaging (CE-SWI) in the Treatment Assessment of Desmoid Fibromatosis: Early results from a Specialized Cancer Institution. San Juan, PR, US.
- 2024. Exhibit, Multi-parametric MRI for the Treatment Assessment of Lower Extremity Soft-Tissue Undifferentiated Pleomorphic Sarcoma (UPS). Conference. Exhibit, Multi-parametric MRI for the Treatment Assessment of Lower Extremity Soft-Tissue Undifferentiated Pleomorphic Sarcoma (UPS). San Juan, PR, US.
- 2023. Exhibit, Optimized automated workflow for radiomic feature extraction from static and dynamic magnetic resonance imaging (MRI)of soft tissue sarcoma. Conference. Exhibit, Optimized automated workflow for radiomic feature extraction from static and dynamic magnetic resonance imaging (MRI)of soft tissue sarcoma. Savannah, GA, US.
- 2023. Exhibit, Diffusion-Weighted imaging first order radiomic features differentiate pelvic chordomas and chondrosarcomas. Conference. Exhibit, Diffusion-Weighted imaging first order radiomic features differentiate pelvic chordomas and chondrosarcomas. Savannah, GA, US.
- 2022. Exhibit, MKEE-30HC: Susceptibility-Weighted Imaging (SWI): Emerging Role in Musculoskeletal Oncology. Conference. Exhibit, MKEE-30HC: Susceptibility-Weighted Imaging (SWI): Emerging Role in Musculoskeletal Oncology. Chicago, IL, US.
- 2022. Exhibit, Baseline, post-treatment and surveillance: advanced magnetic resonance imaging of soft-tissue sarcomas. Conference. Exhibit, Baseline, post-treatment and surveillance: advanced magnetic resonance imaging of soft-tissue sarcomas. Chicago, IL, US.
- 2018. Preoperative CT Angiography for Fibular Free Flap Reconstructions. Conference. Preoperative CT Angiography for Fibular Free Flap Reconstructions. Orlando, FL, US.
- 2018. Gadolinium-Based Intravenous Contrast Administration for Detection of Recurrent Soft Tissue Sarcomas. Conference. Gadolinium-Based Intravenous Contrast Administration for Detection of Recurrent Soft Tissue Sarcomas. Washington, DC, US.
- 2018. Intravenous Contrast Administration for Detection of Recurrent Soft Tissue Sarcomas on MRI. Conference. Intravenous Contrast Administration for Detection of Recurrent Soft Tissue Sarcomas on MRI. Austin, TX, US.
- 2017. Electronic Poster, Flexible spin echo triple echo Dixon (flexible STED) for fat suppressed T1-weighted imaging. Conference. Electronic Poster, Flexible spin echo triple echo Dixon (flexible STED) for fat suppressed T1-weighted imaging. Honolulu, HI, US.
- 2015. Exhibit, Pseudomyogenic Hemangioendothelioma of the Lower Extremity. Conference. Exhibit, Pseudomyogenic Hemangioendothelioma of the Lower Extremity, US.
- 2015. Phase I/II Study of Dasatinib in Combination with Zoledronic Acid (ZA) for the Treatment of Breast Cancer Bone Metastasis (MBC-bone). Conference. TBCRC. Chicago, IL, US.
- 2015. Oral Presentation, 18F-FDG PET/CT as an Indicator of Survival in Bone Primary Ewing Sarcoma. Conference. Oral Presentation, 18F-FDG PET/CT as an Indicator of Survival in Bone Primary Ewing Sarcoma. Scottsdale, AZ, US.
- 2015. Exhibit, Cryoablation of Metastatic Leiomyosarcoma to the Glenoid Fossa. Conference. Exhibit, Cryoablation of Metastatic Leiomyosarcoma to the Glenoid Fossa, US.
- 2014. Oral Presentation, 18F-FDG PET/CT as an Indicator of Survival in Bone Primary Ewing Sarcoma. Conference. Oral Presentation, 18F-FDG PET/CT as an Indicator of Survival in Bone Primary Ewing Sarcoma. Chicago, IL, US.
- 2014. Exhibit, Osteofibrous Dysplasia, Adamantinoma-Like Osteofibrous Dysplasia and Adamantinoma. Conference. Exhibit, Osteofibrous Dysplasia, Adamantinoma-Like Osteofibrous Dysplasia and Adamantinoma, US.
- 2014. Exhibit, Secondary Chondrosarcoma of the Femur. Conference. Exhibit, Secondary Chondrosarcoma of the Femur, US.
- 2013. Exhibit, Bone Windows for Distinguishing Malignant from Benign Primary Bone Tumors on FDG/PET/CT. Conference. Exhibit, Bone Windows for Distinguishing Malignant from Benign Primary Bone Tumors on FDG/PET/CT. San Antonio, TX, US.
- 2011. Oral Presentation, Fast Dixon-based whole body MRI: sensitivity and specificity in comparison with bone scan. Conference. Society of Skeletal Radiology. Scottsdale, AZ, US.
- 2010. Oral Presentation, Case of the Day-Chronic sclerosing osteitis. Conference. Society of Skeletal Radiology. Las Vegas, NV, US.
- 2009. Oral Presentation, The effect of half dose intravenous gadolinium MR contrast on the conspicuity of bone and soft tissue lesions. Conference. 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2009. Oral Presentation, Diagnostic quality of contrast-enhanced T1 FLAIR vs Contrast-enhanced T1 spin echo sagittal imaging in the spine at 3T. Conference. 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2009. Exhibit, Determination of central line position in the superior vena cava or azygous vein on frontal chest radiographs. Conference. 109th Annual Meeting of the American Roentgen Ray Society. Boston, MA, US.
- 2009. Exhibit, Whole Body MRI for evaluation of breast cancer metastases. Conference. ISMRM-18th Annual Section for Magnetic Resonance Technologists Meeting. Honolulu, HI, US.
- 2008. Oral Presentation, FDG PET/CT as an indicator of progression free survival in osteosarcoma. Conference. 94th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2008. Oral Presentation, Physical location of SUVmax on FDG PET/CT in primary osteosarcoma: correlation with histologic sampling of the surgical specimen. Conference. 94th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2008. PET/CT FDG imaging: From a musculoskeletal perspective. Conference. Society of Nuclear Medicine Annual Meeting. New Orleans, LA, US.
- 2008. Exhibit, Incidence of skeletal muscle metastases from non-small cell lung cancer. Conference. Society of Nuclear Medicine Annual Meeting. New Orleans, LA, US.
- 2008. Oral Presentation, Musculoskeletal PET/CT imaging pitfalls. Conference. 108th Annual Meeting of the American Roentgen Ray Society. Washington, DC, US.
- 2007. Oral Presentation and Exhibit, Skeletal muscle metastases: imaging and epidemiology. Conference. 107th Annual Meeting of the American Roentgen Ray Society. Orlando, FL, US.
- 2006. Exhibit, Long term follow-up of chronic sclerosing osteitis of tubular bones. Conference. 92nd Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2004. Exhibit, Imaging characteristics of locally recurrent tumors of bone. Conference. 90th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2004. Exhibit, Magnetic resonance imaging of locally recurrent soft tumors. Conference. 90th Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2003. MRI of the shoulder and knee. Conference. 31st Annual Conference of the American Academy of Physician Assistants. New Orleans, LA, US.
- 2001. Exhibit, CT reformattation in evaluation of fracture healing with metal fixation: correlation with clinical outcome. Conference. 87th Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
International Presentations
- 2025. Exhibit, Multiparametric-MRI (mp-MRI) Baseline Signature Tumor Profile and Pre-surgical Predictive Treatment Response Model for Rhabdomyosarcoma (RMS) (C-28508. Poster. ESR European Congress of Radiology 2025 Educational and Scientific Programme. Vienna, AT.
- 2025. Exhibit, Extension study following successful pilot evaluating contrast-enhanced susceptibility-weighted imaging first-order and high-order radiomics for the assessment of desmoid fibromatosis response (C-13950). Poster. ESR European Congress of Radiology 2025 Educational and Scientific Programme. Vienna, AT.
- 2025. Oral Presentation, Undifferentiated pleomorphic sarcoma: Building an effective multi-parametric MRI (mpMRI) predictive treatment response model to replace RECIST - 13949. Conference. ESR European Congress of Radiology 2025 Educational and Scientific Programme. Vienna, AT.
- 2024. Exhibit, Novel use of contrast-enhanced susceptibility imaging (CE-SWI) in assessing treatment response in extremity soft-tissue undifferentiated pleomorphic sarcoma (UPS). Conference. ESR European Congress of Radiology 2024 Science and Educational Programme. Vienna, AU.
- 2024. Exhibit, Multiparametric MRI for the treatment assessment of lower extremity soft-tissue undifferentiated pleomorphic sarcoma (UPS). Conference. ESR European Congress of Radiology 2024 Science and Educational Programme. Vienna, AT.
- 2024. Exhibit, Perfusion weighted imaging with dynamic contrast enhancement (PWI/DCE) for the treatment assessment of extremity soft-tissue non-myxoid undifferentiated pleomorphic sarcoma. Conference. ESR European Congress of Radiology 2024 Science and Educational Programme. Vienna, AT.
- 2024. Exhibit, Novel use of contrast-enhanced susceptibility-weighted imaging (CE-SWI) in the treatment assessment of desmoid fibromatosis: early results from a specialized cancer institution. Conference. ESR European Congress of Radiology 2024 Science and Educational Programme. Vienna, AT.
- 2024. Exhibit, Advanced MRI can be used to determine percent necrosis in leiomyosarcoma. Conference. ESR European Congress of Radiology 2024 Science and Educational Programme. Vienna, AT.
- 2023. Exhibit, Early results in novel use of contrast-enhanced susceptibility-weighted imaging in the assessment of response and progression in desmoid fibromatosis: pilot study in a specialized cancer institution. Conference. Connective Tissue Oncology Society 2023 Annual Meeting. Dublin, IE.
- 2023. Exhibit, Contrast-enhanced susceptibility imaging (CE-SWI) morphologic, first & high-order radiomic features value in assessing treatment response in extremity soft-tissue undifferentiated pleomorphic sarcoma. Conference. Connective Tissue Oncology Society 2023 Annual Meeting. Dublin, IE.
- 2023. Exhibit, Baseline and post-treatment advanced MRI of extremities soft-tissue non-myxoid undifferentiated pleomorphic sarcoma. Conference. Connective Tissue Oncology Society 2023 Annual Meeting. Dublin, IE.
- 2023. Exhibit, Apparent diffusion coefficient (ADC) high-order radiomic of baseline and post-treatment advanced MRI of extremity soft-tissue non-myxoid undifferentiated pleomorphic sarcoma. Conference. Connective Tissue Oncology Society 2023 Annual Meeting. Dublin, IE.
- 2023. Exhibit, Role of perfusion weighted imaging with dynamic contrast enhanced (PWI/DCE) for the treatment assessment of extremity soft-tissue non-myxoid undifferentiated. Conference. Connective Tissue Oncology Society 2023 Annual Meeting. Dublin, IE.
- 2023. Exhibit, Cancer radiomic and perfusion imaging (CARPI) automated framework: validation on musculoskeletal tumors in a specialized cancer center. Conference. Connective Tissue Oncology Society 2023 Annual Meeting. Dublin, IE.
- 2023. Oral Presentation, Optimized automated workflow for radiomic feature extraction from static and dynamic magnetic resonance imaging (MRI) of soft tissue sarcoma. Conference. ESR European Congress of Radiology 2023 Science and Educational Programme. Vienna, AT.
- 2023. Exhibit, Susceptibility imaging (SWI) morphologic patterns and high-order radiomics of baseline and post-treatment advanced MRI of extremity soft-tissue undifferentiated pleomorphic sarcoma. Conference. ESR European Congress of Radiology 2023 Science and Educational Programme. Vienna, AT.
- 2023. Exhibit, Susceptibility-Weighted imaging (SWI) in benign and malignant tumors of musculoskeletal system (C-19005). Conference. ESR European Congress of Radiology 2023 Science and Educational Programme. Vienna, AT.
- 2023. Exhibit, Apparent diffusion coefficient (ADC) high-order radiomics of baseline and post-treatment advanced MRI of extremity soft-tissue undifferentiated pleomorphic sarcoma (C-20144). Conference. ESR European Congress of Radiology 2023 Science and Educational Programme. Vienna, AT.
- 2023. Oral Presentations, Apparent diffusion coefficient (ADC) first-order radiomic features differentiate pelvic chordomas and chondrosarcomas. Conference. ESR European Congress of Radiology 2023 Science and Educational Programme. Vienna, AT.
- 2023. Oral Presentation, Baseline and post-treatment advanced MRI of extremity soft-tissue non-myxoid undifferentiated pleomorphic sarcomas. Conference. ESR European Congress of Radiology 2023 Science and Educational Programme. Vienna, AT.
- 2022. Presentation, Diffusion-Weighted imaging for differentiation of sacral chordoma and chondrosarcoma. Conference. Connective Tissue Oncology Society. Vancouver, CA.
- 2019. Senior Board Review. Visiting. Musculoskeletal Oncology Residents Oral Board Examinations. Tel Aviv, IL.
- 2019. An Update on Indications for Intravenous Gadolinium-Based MRI Contrast in Musculoskeletal Oncology. Visiting. Diagnostic Imaging. Tel Aviv, IL.
- 2018. A Method for Automatically Determining an Optimal Kernel Size in ESPIRiT Reconstruction(Abstract 6619). Conference. ISMRM-ESMRMB 2018 Joint Annual Meeting. Paris, FR.
- 2018. Preoperative CT Angiography for Fibular Free Flap Reconstructions. Conference. 66th Annual Meeting of the Association of University Radiologists (AUR). Orlando, US.
- 2018. Senior Board Review. Visiting. Musculoskeletal Oncology Residents Oral Board Examinations. Tel Aviv, IL.
- 2018. Indications for Intravenous Gadolinium-Based MRI Contrast in Musculoskeletal Oncology. Visiting. Diagnostic Radiology. Tel Aviv, IL.
- 2017. Electronic Poster, Flexible spin echo triple echo Dixon (flexible STED) for fat suppressed T1-weighted imaging. Conference. 25th Annual Meeting of the International Society for Magnetic Resonance in Medicine. Honolulu, US.
- 2015. Phase I/II Study of Dasatinib in Combination with Zoledronic Acid (ZA) for the Treatment of Breast Cancer Bone Metastasis (MBC-bone). Invited. TBCRC. Chicago, US.
- 2012. Exhibit, FDG PET/CT of Primary Bone Tumors. Conference. 112th Annual Meeting of the American Roentgen Ray Society. Vancouver, CA.
- 2012. Exhibit, MSK Power Hour. Conference. 112th Annual Meeting of the American Roentgen Ray Society. Vancouver, CA.
- 2010. Exhibit, Conspicuity of bone lesions on fast Dixon-based whole body MRI with diffusion-weighted sequences: estimate of clinical utility per sequence. Conference. World Molecular Imaging Conference. Kyoto, JP.
- 2009. Senior Board Reviews. Visiting. Radiology. Tel Aviv, IL.
- 2009. Approach to Bone Tumors. Visiting. Radiology. Tel Aviv, IL.
- 2008. MRI of the Shoulder. Visiting. Radiology. Tel Aviv, IL.
- 2008. Senior Board Review. Visiting. Radiology. Tel Aviv, IL.
- 2008. MRI of the Knee. Visiting. Radiology. Tel Aviv, IL.
- 2007. Oral Presentation, Cartilage Tumors. Conference. International Skeletal Society, 5th Annual Pathology Refresher Course. Budapest, HU.
- 2007. Oral Presentation, Single session whole body T-2 weighted and T-1 weighted MRI (both with and without fat suppression). Conference. International Society of Magnetic Resonance in Medicine. Berlin, DE.
- 2006. Senior Board Review. Visiting. Department of Radiology. Tel Aviv, IL.
- 2006. Imaging of Local Recurrence of Musculoskeletal Neoplasms. Visiting. Department of Radiology. Tel Aviv, IL.
- 2006. Oral Presentation, Cartilage Tumors. Conference. International Skeletal Society, 4th Annual Pathology Refresher Course. Vancouver, CA.
- 2006. Exhibit, Radiography of implantable cardiac pacemakers and defibrillators. Conference. Annual Meeting of the American Roentgen Ray Society. Vancouver, CA.
- 2005. Oral Presentation, Cartilage Tumors. Conference. International Skeletal Society, 3rd Annual Pathology Refresher Course. Singapore, SG.
- 2004. Oral Presentation, Cartilage Tumors. Conference. International Skeletal Society 2nd Annual Pathology Refresher Course. St. Julian's Bay, MT.
Formal Peers
- 2024. Deep Inferior Epigastric Artery Flaps: CT Angiography and Clinical Perspectives. Houston, Texas, US.
- 2023. Dual energy CT (CECT) of gout concepts and updates. Conference. Dual energy CT (CECT) of gout concepts and updates. Houston, TX, US.
- 2023. Advanced Bone and Soft Tissue Imaging: Triumphs, Pitfalls and Questions. Conference. Advanced Bone and Soft Tissue Imaging: Triumphs, Pitfalls and Questions. Houston, TX, US.
- 2023. DECT of Gout. Conference. Musculoskeletal Imaging QA Conference. Houston, TX, US.
- 2022. Indications For Gadolinium-Based MRI Contrast in MSK Oncology. Conference. Indications For Gadolinium-Based MRI Contrast in MSK Oncology. Houston, TX, US.
- 2021. Indications For Gadolinium-Based MRI Contrast in MSK Oncology. Conference. Indications For Gadolinium-Based MRI Contrast in MSK Oncology. Houston, TX, US.
- 2007. Imaging of Cardiac Pacemakers and Defibrillators. Visiting. Imaging of Cardiac Pacemakers and Defibrillators. New Orleans, LA, US.
- 2007. Senior Board Review. Visiting. Senior Board Review. New Orleans, LA, US.
- 2005. Imaging of Local Recurrence of Musculoskeletal Tumors. Visiting. Imaging of Local Recurrence of Musculoskeletal Tumors. New Orleans, LA, US.
- 2005. Senior Board Review. Visiting. Senior Board Review. New Orleans, LA, US.
- 2004. Imaging of Recurrence of Musculoskeletal Neoplasms. Visiting. Imaging of Recurrence of Musculoskeletal Neoplasms. New Orleans, LA, US.
- 2004. Senior Board Review. Visiting. Senior Board Review. New Orleans, LA, US.
- 2002. MRI of the Knee. Visiting. MRI of the Knee. Galveston, TX, US.
Patient Reviews
CV information above last modified April 14, 2025